Current Challenges in the Management of persistent or chronic ITP

 

Moffitt Cancer Center
V

2L Therapies for Chronic and Persistent ITP

By Moffitt Cancer Center FEATURING Vania Phuoc
By Moffitt Cancer Center FEATURING Vania Phuoc
110 views
July 11, 2022
0 Comments
Login to view comments. Click here to Login
Current Challenges in the Management of persistent or chronic ITP
18:26
Moffitt Cancer Center

2L Therapies for Chronic and Persistent ITP

Feat. V. Phuoc
05:00
ASH 2022 Conference Coverage

Cognitive Impairment in Patients With ITP

Feat. C. Vladescu
12:24
Kelsey Martin

Addressing the Management of ITP: Review of the ASH Clinical Practic…

33:35
Platelet Disorder Support Association (PDSA)

The Senior Years: Managing Your ITP

Feat. C. Kessler
20:59
Platelet Disorder Support Association (PDSA)

Blood Clots and ITP Updates

Feat. D. Kuter
12:29
Michael Boxer

Tapering Corticosteroids in ITP and Then What?

15:30
NYU Langone

TPO-RA Agents in Children With ITP: What to Consider in Terms of Tim…

Feat. K. Hillier
19:56
Platelet Disorder Support Association (PDSA)

What Makes ITP Refractory

Feat. J. Bussel
19:58
Platelet Disorder Support Association (PDSA)

New Insights Into What Causes ITP

Feat. J. Semple
23:31
Marc Zumberg

When Steroids Aren't Enough in ITP: Knowing When to Add a TPO-RA

07:15
Weill Cornell Medicine Oncology & Hematology

Eltrombopag in ITP: Learnings From the RAISE and EXTEND Trials

Feat. J. Bussel
24:27
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

ITP: Past and Present

Feat. J. Kelton
28:25
Indy Hematology Review

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Feat. C. Kessler
15:25
Cleveland Clinic Taussig Cancer Institute

Splenectomy for Immune Cytopenias: Treatment Outcomes and Predictors…

Feat. O. Ogbue
11:20
Nicoletta Machin

When Steroids Aren't Enough: Knowing When to Add TPOs to ITP Tr…